CTRI/2018/04/013274已完成2 期
Double blinded, randomized, controlled, single centered study to evaluate safety and efficacy of prickly heat powder.
ITC Limited Peenya Industrial Area Peenya Bangalore0 个研究点目标入组 63 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 63
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.70 volunteers of either gender in age group of 5 to 50 years. At least 10 volunteers in each of the following age brackets: (i) 5-10 yrs, (ii) 11-17 yrs (iii) 18-50 yrs.
- •2.Volunteers with primary symptoms of Miliaria rubra on either of back/forearm/neck/ shoulder/chest/underarm/forehead or more than one of these.
- •3.Volunteers with no history of having used a similar product during or since 1 week prior to the scheduled study commencement.
- •4.Volunteers who show no skin sensitivity symptoms to the investigational products during skin sensitivity test.
- •5.Female volunteers who are neither pregnant nor nursing.
- •6.Volunteers who are willing to abstain from using any product other than the provided cleanser and test product during the study period.
- •7.Volunteers willing to visit the site at specified frequencies for periodic evaluations.
- •8.Volunteers willing to comply with study specific requirements.
- •9.Volunteers willing to give a written informed consent and come for regular observation.
排除标准
- •1.Volunteers with symptoms of Miliaria pustulosa, Miliaria profunda as identified by the dermatologist.
- •2.Volunteers who have participated in similar kind of investigation in the past four weeks.
- •3.Volunteers having infections on skin/ nail that could spread or interfere with the test readings.
- •4.Volunteers with a known history or current condition of allergy or sensitivity to cosmetic products/ fragrances
- •5.Volunteers on medications (e.g. steroids or antihistamines) that could compromise the study.
- •6.Volunteers who are undergoing any medical treatment or taking any systemic medicines since 4 weeks prior to study commencement or applying any topical medication within 2 weeks prior to study commencement which could compromise the study.
研究者
相似试验
已完成
不适用
Hypertonic saline in cutaneous leishmaniasisCutaneous leishmaniasisSLCTR/2013/024Teaching Hospital Anuradhapura
已完成
不适用
Randomized, ControlleD, Single Blinded, ProspEctive, MuLtIcenter Study EValuating Anatomic versus Targeted lead placement for Burst DR Therapy during the Trial Evaluation periodNL-OMON45537St. Jude Medical40
暂停
Unknown
A clinical trial to evaluate the temporary cognitive function improvement effect and safety of a low-frequency stimulation treatment device for 9 months in patients with Alzheimer's type mild cognitive impairment receiving drug treatment.Mental and behavioural disordersKCT0009136Ecure30
进行中(未招募)
不适用
Singleblind, randomized, verum-controlled, multicentric study to confirm the non-inferiority of Leukichtan Gel versus Betaisodona Salbe in the treatment of cuts, abrasions and burnsEUCTR2007-000532-47-DEICHTHYOL-GESELLSCHAFT Cordes, Hermanni & Co. (GmbH & Co.) KG
进行中(未招募)
不适用
Monocenter, double blinded, prospective, randomized, placebo controlled study investigating prevention of Major Adverse Cardiac Events (MACE) after 6 months by systemic treatment with Everolimus after coronary intervention with bare metal stents in patients with significant coronary artery disease - Restenosis-Studycoronary artery diseasecoronary intervention with bare metal stentsEUCTR2005-002992-34-DEDeutsches Herzzentrum Berlin
